NHERF1 and colorectal carcinoma: Interestingly, the PAR-2(+)/cytoplasmic NHERF1(+) expression immunophenotype was able to predict poor prognosis of CRC patients, being associated with the presence of nodal and distant metastasis, poor differentiation grade and LVI.